Physician

Aleksandra Gabriela Florek, M.D.

According to 2025 Medicare claims, Aleksandra Florek, M.D. (NPI: 1417364670) practices dermatology in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Lake, IN. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1659796225; TIN: 391351587) and primary practice location at 46307-1710. Florek is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), participating under the MSSP model.

Florek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,069 traditional Medicare patients, billed 6,809 HCPCS/CPT codes, and received $782,622 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 3,117 prescription claims across 1,088 beneficiaries totaling $1,103,568 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 204 records totaling $7,158. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,269 to $1,103,568. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$393K$785K2020 Medicare payment: $33,461 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $509,669 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $743,921 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $785,095 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $782,622 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020127447$33,461
20218824,395$509,669
20229195,191$743,921
20239576,446$785,095
20241,0696,809$782,622

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$552K$1.1M2020 Drug cost: $3,269 (USD; Tot_Drug_Cst)2021 Drug cost: $74,474 (USD; Tot_Drug_Cst)2022 Drug cost: $565,603 (USD; Tot_Drug_Cst)2023 Drug cost: $709,839 (USD; Tot_Drug_Cst)2024 Drug cost: $1,103,568 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20206091$3,269
2021381696$74,474
20228151,780$565,603
20239202,177$709,839
20241,0883,117$1,103,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks269351$471
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more500818$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more421562$60
17000Destruction of precancer skin growth, 1 growth361504$37
17003Destruction of precancer skin growth, 2-14 growths2721,287$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa241,848$500,716
Cosentyx Unoready PenSecukinumab11308$104,252
Taltz AutoinjectorIxekizumab13364$93,666
FluorouracilFluorouracil1835,313$13,771
Doxycycline MonohydrateDoxycycline Monohydrate69012,454$11,171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.204$7,158Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aleksandra Gabriela Florek, M.D.?

Tedicare shows public-source Medicare data for Aleksandra Gabriela Florek, M.D. (NPI 1417364670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aleksandra Gabriela Florek, M.D. have ACO affiliation data?

Aleksandra Gabriela Florek, M.D. is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550).

What billing organization is linked to Aleksandra Gabriela Florek, M.D.?

Aleksandra Gabriela Florek, M.D. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1659796225) in the available physician profile data.

Does Aleksandra Gabriela Florek, M.D. have Open Payments data?

Aleksandra Gabriela Florek, M.D. has 204 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.